Amanda Lipsitt MD

San Antonio native | Passionate about Pedi BMT and cellular therapy @SarahCannonDocs @HCAhealthcare | Past St. Jude BMTCT and UTH-SA PHO fellow, views my own

[Amanda Lipsitt MD @ALipsitt]

Excited to publish our experience treating DSA in pedi & AYA receiving a haplo transplant! DSA’s are a problem when you don’t have many donor options. Use a multimodality treatment approach including inhibiting production, neutralization, and removal of antibodies. | PBC journal

[Akshay Sharma MD @AkshaySharmaMD]

How to manage donor-specific antibodies in children receiving a #BMTsm? 🤔
Wonder no more 👉 former @StJudeResearch fellow and current @SarahCannonDocs #PHOdoc @ALipsitt described what to do to prepare patients for a transplant #desensitization @ASPHO_hq
https://t.co/1rgnIGFPgm

[Akshay Sharma MD @AkshaySharmaMD]

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma is feasible and improves survival #BMTsm #Immunotherapy https://t.co/48dajbNKHO

[Akshay Sharma MD @AkshaySharmaMD]

In our latest publication in @BloodJournal, @pigtowner and I report an increase in myocardial extracellular volume (ECV) in patients with #SickleCell disease despite early intervention with disease-modifying therapies ☹️ https://t.co/QlaTivyk1y

[Starzl Transplantation Institute @InstituteStarzl]

A medical breakthrough for patients, FK-506 was a more effective and potent immunosuppressant than what had been used previously. Dr. Starzl and his team of researchers were instrumental in its development and in providing support for its widespread use.

[Amanda Lipsitt MD @ALipsitt]

The end to a great #tandem23 conference…learned a ton, presented a couple posters, and connected with friends old and new. Can’t wait to see everyone next year in my home city of San Antonio! #tandem24 @PaulS1594 @BldCancerDoc @LEAppell @ASTCT

[Amanda Lipsitt MD @ALipsitt]

Excited to be at the first day of Tandem with these awesome colleagues! #Tandem23 @ASTCT @PaulS1594 @CarlosBachier @SarahCannonDocs

[Krishna Komanduri, MD, FASTCT @drkomanduri]

Proud to work with @NiraliShahMD on the @ASTCT cell therapy committee.

In addition to her many contributions to breakthrough trials in children, she has led efforts to describe CAR-T toxicities, including #tcellrx hemophagocyctic syndromes (now termed IEC-HS).

#immunotherapy

[Amanda Lipsitt MD @ALipsitt]

@Joeycules Felt it in the medical center too!

[Akshay Sharma MD @AkshaySharmaMD]

N-Acetylcysteine as Prophylactic Therapy for Transplantation-Associated Thrombotic Microangiopathy: A Randomized, Placebo-Controlled Trial https://t.co/3LmmjiGnPN

[Lauren Gambill, MD MPA (she/her) @renkate]

It's moments like these that define us.

We certainly have the choice to sulk. But we also have the power to act.

[Amanda Lipsitt MD @ALipsitt]

Check out an interesting case I had when I was a fellow at St. Jude that I presented last summer at @ebmt transplant course! Thank you @TheEBMT_Trainee for asking me to participate in one of your twitter cases 😊

[EBMT Trainee Committee @TheEBMT_Trainee]

Welcome to our 4th Twitter Case: How to Make a Host More Hospitable - Desensitization of Donor Specific Anti-HLA Antibodies! This case was presented by @ALipsitt at @TheEBMT International Transplant Course this year! If you are interested in contributing please DM @larsgjaerde!👇

[Lauren Ball @ProfLaurenBall]

Writing a great abstract can be tricky! This writing template by @Nature is super helpful 👉

[Lauren Gambill, MD MPA (she/her) @renkate]

Doctors don’t vote. We say we do… but voting is public record and data tells a different story.

I don’t have time to judge anyone, so here are some solutions instead.

What can we do about it today. 🧵

[Amanda Lipsitt MD @ALipsitt]

@AlbertoLima_HLA @AkshaySharmaMD @StJudeResearch @SarahCannonDocs @ASPHO_hq Thank you! 😊

[Nico Gagelmann @NicoGagelmann]

Surround yourself with positive people. Also, be a positive person. Root for people. Somebody else's success is not your failure.

[Akshay Sharma MD @AkshaySharmaMD]

How to manage donor-specific antibodies in children receiving a #BMTsm? 🤔
Wonder no more 👉 former @StJudeResearch fellow and current @SarahCannonDocs #PHOdoc @ALipsitt described what to do to prepare patients for a transplant #desensitization @ASPHO_hq
https://t.co/1rgnIGFPgm

[Amanda Lipsitt MD @ALipsitt]

Looking forward to working with this amazing team! 😊 @SarahCannonDocs @MethodistMDs_SA @BldCancerDoc @PaulS1594 @CarlosBachier @hfrangoul

[Methodist Physicians @MethodistMDs_SA]

While growing up in the Alamo City, Dr. Amanda Lipsitt seemed destined for a life in medicine. She attended Health Careers and enjoyed visiting hospitals with her pediatrician father. Fast forward and now we get to welcome her to our team! Learn more:
https://t.co/n2KHWNJAdZ

[Methodist Physicians @MethodistMDs_SA]

While growing up in the Alamo City, Dr. Amanda Lipsitt seemed destined for a life in medicine. She attended Health Careers and enjoyed visiting hospitals with her pediatrician father. Fast forward and now we get to welcome her to our team! Learn more:
https://t.co/n2KHWNJAdZ

[Akshay Sharma MD @AkshaySharmaMD]

An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory 🤯 https://t.co/motzJPYIZP

[Michael Makris @ProfMakris]

So far 4 cancers have occurred in #hemophilia patients who have undergone gene therapy with AAV vectors. Salivary gland cancer and ALL in the Biomarin trial, Hepatocellular Carcinoma in the UniQure trial and Tonsil cancer in a Baxter trial. 1/3